144 related articles for article (PubMed ID: 1533964)
21. Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes.
Watanabe M; Watanabe N; Maruyama S; Kawashiro T
Drug Metab Pharmacokinet; 2015 Oct; 30(5):325-33. PubMed ID: 26423799
[TBL] [Abstract][Full Text] [Related]
22. Prevention of estrogen carcinogenesis in the hamster kidney by ethinylestradiol: some unique properties of a synthetic estrogen.
Li JJ; Hou X; Bentel J; Yazlovitskaya EM; Li SA
Carcinogenesis; 1998 Mar; 19(3):471-7. PubMed ID: 9525282
[TBL] [Abstract][Full Text] [Related]
23. The effect of toremifene on lipid metabolism compared with that of tamoxifen in vitro.
Sawaki M; Idota A; Uchida H; Noda S; Sato S; Kikumori T; Imai T
Gynecol Obstet Invest; 2011; 71(3):213-6. PubMed ID: 21196696
[TBL] [Abstract][Full Text] [Related]
24. Histopathology and histomorphometry of the urogenital tract in 15-month old male and female rats treated neonatally with SERMs and estrogens.
Karlsson S
Exp Toxicol Pathol; 2006 Aug; 58(1):1-12. PubMed ID: 16709447
[TBL] [Abstract][Full Text] [Related]
25. Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifen.
Kim J; Coss CC; Barrett CM; Mohler ML; Bohl CE; Li CM; He Y; Veverka KA; Dalton JT
Int J Cancer; 2013 Mar; 132(6):1475-85. PubMed ID: 22915089
[TBL] [Abstract][Full Text] [Related]
26. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.
Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM
Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624
[TBL] [Abstract][Full Text] [Related]
27. Estrogen modulation of nuclear matrix-associated steroid hormone binding.
Simmen RC; Means AR; Clark JH
Endocrinology; 1984 Sep; 115(3):1197-202. PubMed ID: 6430682
[TBL] [Abstract][Full Text] [Related]
28. Crossover trial for lipid abnormality in postmenopausal breast cancer patients during selective estrogen receptor modulators (SERMs) administrations.
Kusama M; Kaise H; Nakayama S; Ota D; Misaka T; Aoki T
Breast Cancer Res Treat; 2004 Nov; 88(1):9-16. PubMed ID: 15538041
[TBL] [Abstract][Full Text] [Related]
29. [Inhibitory effect of tamoxifen on the breast cancer risk induced by exogenous estrogen in rat].
Zeng X; Yao Z
Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):176-9. PubMed ID: 9387675
[TBL] [Abstract][Full Text] [Related]
30. Chronic exposure to estrogen and tamoxifen regulates synaptophysin and phosphorylated cAMP response element-binding (CREB) protein expression in CA1 of ovariectomized rat hippocampus.
Sharma K; Mehra RD; Dhar P; Vij U
Brain Res; 2007 Feb; 1132(1):10-9. PubMed ID: 17161830
[TBL] [Abstract][Full Text] [Related]
31. Effect of neonatal exposure to diethylstilbestrol and tamoxifen on pelvis and femur in male mice.
Fukazawa Y; Nobata S; Katoh M; Tanaka M; Kobayashi S; Ohta Y; Hayashi Y; Iguchi T
Anat Rec; 1996 Mar; 244(3):416-22. PubMed ID: 8742705
[TBL] [Abstract][Full Text] [Related]
32. Kinetic studies of the radical-scavenging activity of estrogens and antiestrogens.
Fujisawa S; Kadoma Y
Anticancer Res; 2004; 24(6):3931-7. PubMed ID: 15736434
[TBL] [Abstract][Full Text] [Related]
33. Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
Pyrhönen S; Valavaara R; Modig H; Pawlicki M; Pienkowski T; Gundersen S; Bauer J; Westman G; Lundgren S; Blanco G; Mella O; Nilsson I; Hietanen T; Hindy I; Vuorinen J; Hajba A
Br J Cancer; 1997; 76(2):270-7. PubMed ID: 9231932
[TBL] [Abstract][Full Text] [Related]
34. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
[TBL] [Abstract][Full Text] [Related]
35. Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human P450 cDNAs (MCL-5 cells).
Styles JA; Davies A; Davies R; White IN; Smith LL
Carcinogenesis; 1997 Feb; 18(2):303-13. PubMed ID: 9054622
[TBL] [Abstract][Full Text] [Related]
36. Mouse bioassay to assess oestrogenic and anti-oestrogenic compounds: hydroxytamoxifen, diethylstilbestrol and genistein.
Köhlerová E; Skarda J
J Vet Med A Physiol Pathol Clin Med; 2004 Jun; 51(5):209-17. PubMed ID: 15315699
[TBL] [Abstract][Full Text] [Related]
37. Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
Lee ES; Schafer JM; Yao K; England G; O'Regan RM; De Los Reyes A; Jordan VC
Clin Cancer Res; 2000 Dec; 6(12):4893-9. PubMed ID: 11156249
[TBL] [Abstract][Full Text] [Related]
38. The effects of tamoxifen and toremifene on bone cells involve changes in plasma membrane ion conductance.
Lehenkari P; Parikka V; Rautiala TJ; Weckström M; Dahllund J; Härkönen PL; Väänänen HK
J Bone Miner Res; 2003 Mar; 18(3):473-81. PubMed ID: 12619932
[TBL] [Abstract][Full Text] [Related]
39. Toremifene and tamoxifen in advanced breast cancer--a double-blind cross-over trial.
Stenbygaard LE; Herrstedt J; Thomsen JF; Svendsen KR; Engelholm SA; Dombernowsky P
Breast Cancer Res Treat; 1993; 25(1):57-63. PubMed ID: 8518408
[TBL] [Abstract][Full Text] [Related]
40. Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer.
Hayes DF; Van Zyl JA; Hacking A; Goedhals L; Bezwoda WR; Mailliard JA; Jones SE; Vogel CL; Berris RF; Shemano I
J Clin Oncol; 1995 Oct; 13(10):2556-66. PubMed ID: 7595707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
